University Hospital of Leipzig Department of Ophthalmology
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rehak, Matus
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
CoRaLa II, NCT04444492: Combination of Ranibizumab and Targeted Laser Photocoagulation

Recruiting
3
110
Europe
Ranibizumab Injection, Lucentis, Laser photocoagulation
University of Giessen, University of Leipzig
Central Retinal Vein Occlusion With Macular Edema
07/25
07/25
EU-ROP, NCT04939571: European Disease Registry on Retinopathy of Prematurity (ROP)

Recruiting
N/A
3000
Europe, RoW
Registry of preterm born infants with treatment-requiring ROP
University Medicine Greifswald
Retinopathy of Prematurity
08/38
08/39
Ziemssen, Focke
CoRaLa II, NCT04444492: Combination of Ranibizumab and Targeted Laser Photocoagulation

Recruiting
3
110
Europe
Ranibizumab Injection, Lucentis, Laser photocoagulation
University of Giessen, University of Leipzig
Central Retinal Vein Occlusion With Macular Edema
07/25
07/25
EyeMatics, NCT06810011: Eye Diseases "Treated" with Interoperable Medical Informatics

Recruiting
N/A
2000
Europe
University Hospital Muenster, University Medicine Greifswald, University Medical Center Mainz, University Hospital, Aachen, Klinikum Chemnitz gGmbH, Technische Universität Dresden, University of Leipzig, University Hospital Tuebingen, Deutsche Ophthalmologische Gesellschaft e.V., Pro Retina Deutschland e.V.
Intravitreal Injections
02/28
02/28

Download Options